The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding.
Open accessAbstract
The subendothelial retention of LDLs through their interaction with proteoglycans has been proposed to be a key process in the pathogenesis of atherosclerosis. In vitro studies have identified eight clusters of basic amino acids in delipidated apo-B100, the protein moiety of LDL, that bind the negatively charged proteoglycans. To determine which of these sites is functional on the surface of LDL particles, we analyzed the proteoglycan-binding activity of recombinant human LDL isolated from transgenic mice. Substitution of neutral amino acids for the basic amino acids residues in site B (residues 3359-3369) abolished both the receptor-binding and the proteoglycan-binding activities of the recombinant LDL. Chemical modification of the remaining basic residues caused only a marginal further reduction in proteoglycan binding, indicating that site B is the primary proteoglycan-binding site of LDL. Although site B was essential for normal receptor-binding and proteoglycan-binding activities, these activities could be separated in recombinant LDL containing single-point mutation. Recombinant LDL with a K3363E mutation, in which a glutamic acid had been inserted into the basic cluster RKR in site B, had normal receptor binding but interacted defectively with proteoglycans; in contrast, another mutant LDL, R3500Q, displayed defective receptor binding but interacted normally with proteoglycans. LDL with normal receptor-binding activity but with severely impaired proteoglycan binding will be a unique resource for analyzing the importance of LDL- proteoglycan interaction in atherogenesis. If the subendothelial retention of LDL by proteoglycans is the initial event in early atherosclerosis, then LDL with defective proteoglycan binding may have little or no atherogenic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes
Jackson, R. L., Busch, S. J., & Cardin, A. D. (1991) · Physiological Reviews · doi:10.1152/physrev.1991.71.2.481 · Cited by 1,094
Basu, S. K., Goldstein, J. L., Anderson, G. W., & Brown, M. S. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.9.3178 · Cited by 1,021
Cell Biology of Atherosclerosis
Ross, R. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.004043 · Cited by 1,003
Weisgraber, K. H., Innerarity, T. L., & Mahley, R. W. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34284-9 · Cited by 618
Self-citationRelease of low density lipoprotein from its cell surface receptor by sulfated glycosaminoglycans
Goldstein, J. L., Basu, S. K., Brunschede, G. Y., & Brown, M. S. (1976) · Cell · doi:10.1016/0092-8674(76)90258-0 · Cited by 613
Mahley, R. W., Innerarity, T. L., Pitas, R. E., Weisgraber, K. H., Brown, J. H., & Gross, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)66966-8 · Cited by 383
Self-citationSchönherr, E., Järveläinen, H. T., Sandell, L. J., & Wight, T. N. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)47419-x · Cited by 334
Self-citationLinton, M. F., Farese, R. V., Chiesa, G., Grass, D. S., Chin, P., Hammer, R. E., Hobbs, H. H., & Young, S. G. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116927 · Cited by 246
Human apolipoprotein E. Determination of the heparin binding sites of apolipoprotein E3.
Weisgraber, K. H., Rall, S. C., Mahley, R. W., Milne, R. W., Marcel, Y. L., & Sparrow, J. T. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35898-2 · Cited by 240
Histological and immunofluorescent studies on the evolution of the human atheromatous plaque
Walton, K. W., & Williamson, N. (1968) · Journal of Atherosclerosis Research · doi:10.1016/s0368-1319(68)80020-1 · Cited by 237
Boren, J., Lee, I., Zhu, W., Arnold, K., Taylor, S., & Innerarity, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1847 · Cited by 234
Self-citationCamejo, G., Olofsson, S. O., Lopez, F., Carlsson, P., & Bondjers, G. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.4.368 · Cited by 198
Human apolipoprotein B-100 heparin-binding sites.
Weisgraber, K. H., & Rall, S. C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60931-7 · Cited by 193
Lipoprotein-receptor interactions
Innerarity, T. L., Pitas, R. E., & Mahley, R. W. (1986) · Methods in Enzymology · doi:10.1016/0076-6879(86)29091-6 · Cited by 186
Self-citationTabas, I., Li, Y., Brocia, R. W., Xu, S. W., Swenson, T. L., & Williams, K. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80745-5 · Cited by 180
Proteoglycans synthesized by smooth muscle cells derived from monkey (Macaca nemestrina) aorta.
Chang, Y., Yanagishita, M., Hascall, V. C., & Wight, T. N. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)81946-2 · Cited by 174
Self-citationSchönherr, E., Järveläinen, H. T., Kinsella, M. G., Sandell, L. J., & Wight, T. N. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.7.1026 · Cited by 166
Self-citationHurt-Camejo, E., Olsson, U., Wiklund, O., Bondjers, G., & Camejo, G. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1011 · Cited by 165
Mahley, R. W., Weisgraber, K. H., & Innerarity, T. L. (1979) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(79)90133-4 · Cited by 154
Self-citationCharacterization of monoclonal antibodies against human low density lipoprotein.
Milne, R. W., Théolis, R., Verdery, R. B., & Marcel, Y. L. (1983) · Arteriosclerosis An Official Journal of the American Heart Association Inc · doi:10.1161/01.atv.3.1.23 · Cited by 145
Camejo, G., Fager, G., Rosengren, B. E., Hurt‐Camejo, E., & Bondjers, G. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85218-3 · Cited by 143
Ji, Z. S., Fazio, S., & Mahley, R. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36849-7 · Cited by 138
Cardoso, L. E. M., & Mourão, P. A. S. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.1.115 · Cited by 112
Véniant, M. M., Pierotti, V, Newland, D., Cham, C. M., Sanan, D. A., Walzem, R. L., & Young, S. G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119511 · Cited by 100
Effect of arterial proteoglycans on the interaction of LDL with human monocyte-derived macrophages
Hurt, E., & Camejo, G. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90272-3 · Cited by 97
Olsson, U., Camejo, G., Hurt-Camejo, E., Elfsber, K., Wiklund, O., & Bondjers, G. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.1.149 · Cited by 94
Hirose, N., Blankenship, D. T., Krivanek, Jackson, R. L., & Cardin, A. D. (1987) · Biochemistry · doi:10.1021/bi00391a044 · Cited by 92
Proteoglycans and lipoproteins in atherosclerosis
Camejo, G., Hurt‐Camejo, E., Olsson, U., & Bondjers, G. (1993) · Current Opinion in Lipidology · doi:10.1097/00041433-199310000-00007 · Cited by 71
Transgenic Mice That Overexpress Mouse Apolipoprotein B
McCormick, S. P. A., Ng, J. K., Véniant, M. M., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.20.11963 · Cited by 65
Paananen, K., & Kovanen, P. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42130-2 · Cited by 64
Hoff, H. F., & Wagner, W. D. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90143-7 · Cited by 61
An ultrastructural study of lipoprotein accumulation in cardiac valves of the rabbit.
Nievelstein, P. F. E. M., Mottino, G. A., Fogelman, A. M., & Frank, J. A. (1994) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.14.7.1151 · Cited by 61
Arterial wall proteoglycans--Biological properties related to pathogenesis of atherosclerosis
Radhakrishnamurthy, B., Srinivasan, S. R., Vijayagopal, P., & Berenson, G. S. (1990) · European Heart Journal · doi:10.1093/eurheartj/11.suppl_e.148 · Cited by 54
Affinity of LDL to a human arterial proteoglycan among male survivors of myocardial infarction
LINDÉN, T., Bondjers, G., Camejo, G., Bergstrand, R. H., Wilhelmsen, L., & Wiklund, O. (1989) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1989.tb00193.x · Cited by 52
Ludwig, E. H., Hopkins, P. N., Allen, A., Wu, L., Williams, R. R., Anderson, J. L., Ward, R. H., Lalouel, J.-M., & Innerarity, T. L. (1997) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)37419-8 · Cited by 52
Self-citationCamejo, G., Rosengren, B. E., Olson, U., Lopez, F., Olofson, S.-O., Westerlund, C., & Bondjers, G. (1990) · European Heart Journal · doi:10.1093/eurheartj/11.suppl_e.164 · Cited by 50
Borén, J., Lee, I., Callow, M. J., Rubin, E. M., & Innerarity, T. L. (1996) · Genome Research · doi:10.1101/gr.6.11.1123 · Cited by 45
Self-citationYao, Z., Blackhart, B. D., Johnson, D. F., Taylor, S., Haubold, K. W., & McCarthy, B. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48411-6 · Cited by 41
Ismail, N. A. E., ALAVI, M. Z., & Moore, S. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90010-8 · Cited by 40
Physical-chemical interaction of heparin and human plasma low-density lipoproteins
Cardin, A. D., Randall, C. J., Hirose, N., & Jackson, R. L. (1987) · Biochemistry · doi:10.1021/bi00391a045 · Cited by 40
Dunning, A. M., Houlston, R. S., Frostegård, J., Revill, J. A., Nilsson, J., Hamsten, A., Talmud, P. J., & Humphries, S. E. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(91)90010-7 · Cited by 30
Galis, Z. S., ALAVI, M. Z., & Moore, S. (1993) · PubMed · Cited by 29
Cited by
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Borén, J., Chapman, M. J., Krauss, R. M., Packard, C. J., Bentzon, J. F., Binder, C. J., Daemen, M. J., Demer, L. L., Hegele, R. A., Nicholls, S. J., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz962 · Cited by 1,601
Self-citationTabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J. (2002) · Nature · doi:10.1038/nature00804 · Cited by 1,019
Self-citation
Metadata
- Authors
- Borén, J., Olin, K., Lee, I., Chait, A., Wight, T. N., & Innerarity, T. L.
- Venue
- Journal of Clinical Investigation
- Published
- 1998-06-15
- Volume
- 101
- Issue
- 12
- Pages
- 2658-2664
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2045868118
- Cited by
- 320
- References
- 43
- FWCI
- 17.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.